This academic paper was originally published by Science Direct, citing the trials of Yuval Zolotov from the Regional Drug and Alcohol Research Centre, Ben Gurion University of the Negev, Israel. The objectives of this trial were to assess the motivation of cancer survivors to consume medical cannabis and to assess their patterns of use, perceived efficacy, as well as side and adverse effects. This was a cross-sectional survey among 190 Israeli cancer survivors who were licensed to use medical cannabis in a single institution. In addition to demographic information, the questionnaire examined patterns of use including:
Share this post
Preliminary Assessment: Medical cannabis…
Share this post
This academic paper was originally published by Science Direct, citing the trials of Yuval Zolotov from the Regional Drug and Alcohol Research Centre, Ben Gurion University of the Negev, Israel. The objectives of this trial were to assess the motivation of cancer survivors to consume medical cannabis and to assess their patterns of use, perceived efficacy, as well as side and adverse effects. This was a cross-sectional survey among 190 Israeli cancer survivors who were licensed to use medical cannabis in a single institution. In addition to demographic information, the questionnaire examined patterns of use including: